Ampyra (dalfampridine) is a prescription potassium channel blocker used to improve mobility in adults with multiple sclerosis. However, it is not currently known whether Ampyra is safe or effective in children under 18 years of age. In this article, we will provide useful information for you to better understand the uses, indications and precautions when using Ampyra.

Palliative therapies (DMTs) can be an important part of the management and treatment of multiple sclerosis (MS). They can prevent flare-ups and delay or stop the progression of MS to more severe levels.